CHINOOK THERAPEUTICS, INC. Quarterly Share-based Payment Arrangement, Expense in USD from Q3 2015 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Chinook Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q3 2015 to Q2 2023.
  • Chinook Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2023 was $9.19M, a 93.1% increase year-over-year.
  • Chinook Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2023 was $28.1M, a 78.7% increase year-over-year.
  • Chinook Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $20.1M, a 56.9% increase from 2021.
  • Chinook Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $12.8M, a 254% increase from 2020.
  • Chinook Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2020 was $3.61M, a 3701% increase from 2019.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 $28.1M $9.19M +$4.43M +93.1% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-07
Q1 2023 $23.7M $7.91M +$3.64M +85.3% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $20.1M $5.71M +$2.28M +66.6% Oct 1, 2022 Dec 31, 2022 10-K 2023-02-27
Q3 2022 $17.8M $5.32M +$2.03M +61.8% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $15.7M $4.76M +$1.17M +32.4% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 $14.6M $4.27M +$1.79M +72.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $12.8M $3.43M +$528K +18.2% Oct 1, 2021 Dec 31, 2021 10-K 2023-02-27
Q3 2021 $12.3M $3.29M +$2.97M +943% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $9.29M $3.6M +$3.3M +1102% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 $5.99M $2.48M +$2.38M +2378% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $3.61M $2.9M +$12.9M Oct 1, 2020 Dec 31, 2020 10-K 2023-02-27
Q3 2020 -$9.31M $315K -$2.76M -89.8% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 -$6.55M $299K -$3.04M -91% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 -$3.51M $100K -$3.6M -97.3% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12
Q4 2019 $95K -$10M -$14M -350% Oct 1, 2019 Dec 31, 2019 10-K 2021-04-07
Q3 2019 $14.1M $3.08M -$1.15M -27.2% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $15.3M $3.34M -$991K -22.9% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-03
Q1 2019 $16.3M $3.7M -$1.22M -24.8% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-04
Q4 2018 $17.5M $4M -$364K -8.34% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-09
Q3 2018 $17.8M $4.22M +$197K +4.9% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 $17.6M $4.33M +$329K +8.23% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-01
Q1 2018 $17.3M $4.92M +$936K +23.5% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
Q4 2017 $16.4M $4.37M +$212K +5.1% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-09
Q3 2017 $16.2M $4.02M +$240K +6.34% Jul 1, 2017 Sep 30, 2017 10-Q 2018-10-30
Q2 2017 $15.9M $4M +$673K +20.2% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-01
Q1 2017 $15.3M $3.99M +$245K +6.55% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-02
Q4 2016 $15M $4.15M Oct 1, 2016 Dec 31, 2016 10-K 2019-02-27
Q3 2016 $3.78M +$1.9M +101% Jul 1, 2016 Sep 30, 2016 10-Q 2017-10-31
Q2 2016 $3.33M Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-02
Q1 2016 $3.74M Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-02
Q3 2015 $1.89M Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.